These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34673359)

  • 1. Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis.
    Sahni S; Gupta G; Sarda R; Pandey S; Pandey RM; Sinha S
    Diabetes Metab Syndr; 2021; 15(6):102308. PubMed ID: 34673359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
    Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
    Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
    Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients.
    Silverio A; Di Maio M; Citro R; Esposito L; Iuliano G; Bellino M; Baldi C; De Luca G; Ciccarelli M; Vecchione C; Galasso G
    BMC Cardiovasc Disord; 2021 Jan; 21(1):23. PubMed ID: 33413093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cardiovascular and metabolic diseases on the severity of COVID-19: a systematic review and meta-analysis.
    Meng M; Zhao Q; Kumar R; Bai C; Deng Y; Wan B
    Aging (Albany NY); 2020 Nov; 12(22):23409-23421. PubMed ID: 33199670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis.
    Honardoost M; Janani L; Aghili R; Emami Z; Khamseh ME
    Cerebrovasc Dis; 2021; 50(2):132-140. PubMed ID: 33530081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes increases the mortality of patients with COVID-19: a meta-analysis.
    Wu ZH; Tang Y; Cheng Q
    Acta Diabetol; 2021 Feb; 58(2):139-144. PubMed ID: 32583078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Underlying Comorbidities on Mortality in SARS-COV-2 Infected Cancer Patients: A Systematic Review and Meta-Analysis.
    Kaur H; Thakur JS; Paika R; Advani SM
    Asian Pac J Cancer Prev; 2021 May; 22(5):1333-1349. PubMed ID: 34048161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
    Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality risk factors of COVID-19 infection in kidney transplantation recipients: a systematic review and meta-analysis of cohorts and clinical registries.
    Udomkarnjananun S; Kerr SJ; Townamchai N; Susantitaphong P; Tulvatana W; Praditpornsilpa K; Eiam-Ong S; Avihingsanon Y
    Sci Rep; 2021 Oct; 11(1):20073. PubMed ID: 34625642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis.
    Cheng S; Zhao Y; Wang F; Chen Y; Kaminga AC; Xu H
    Medicine (Baltimore); 2021 Mar; 100(12):e24971. PubMed ID: 33761654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory factors associated with coronavirus disease 2019 (Covid-19): A systematic review and meta-analysis.
    Minh LHN; Abozaid AA; Ha NX; Le Quang L; Gad AG; Tiwari R; Nhat-Le T; Quyen DK; Al-Manaseer B; Kien ND; Vuong NL; Zayan AH; Nhi LHH; Surya Dila KA; Varney J; Tien Huy N
    Rev Med Virol; 2021 Nov; 31(6):e2288. PubMed ID: 34472152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic risk factors and risk of Covid-19: A systematic review and meta-analysis.
    Moazzami B; Chaichian S; Kasaeian A; Djalalinia S; Akhlaghdoust M; Eslami M; Broumand B
    PLoS One; 2020; 15(12):e0243600. PubMed ID: 33320875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and comorbidities: a systematic review and meta-analysis.
    Gold MS; Sehayek D; Gabrielli S; Zhang X; McCusker C; Ben-Shoshan M
    Postgrad Med; 2020 Nov; 132(8):749-755. PubMed ID: 32573311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-Cerebrovascular Disease is Associated With Severity and Mortality of COVID-19: A Systematic Review and Meta-Analysis.
    Yu JN; Wu BB; Yang J; Lei XL; Shen WQ
    Biol Res Nurs; 2021 Apr; 23(2):258-269. PubMed ID: 32851851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
    J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients.
    Brojakowska A; Eskandari A; Bisserier M; Bander J; Garikipati VNS; Hadri L; Goukassian DA; Fish KM
    PLoS One; 2021; 16(7):e0253660. PubMed ID: 34228746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
    Jakob CEM; Borgmann S; Duygu F; Behrends U; Hower M; Merle U; Friedrichs A; Tometten L; Hanses F; Jung N; Rieg S; Wille K; Grüner B; Klinker H; Gersbacher-Runge N; Hellwig K; Eberwein L; Dolff S; Rauschning D; von Bergwelt-Baildon M; Lanznaster J; Strauß R; Trauth J; de With K; Ruethrich M; Lueck C; Nattermann J; Tscharntke L; Pilgram L; Fuhrmann S; Classen A; Stecher M; Schons M; Spinner C; Vehreschild JJ
    Infection; 2021 Feb; 49(1):63-73. PubMed ID: 33001409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.